Infectious diseases are analogous with cancer. Hypothesis and implications

Journal of Cancer

Volumn 3, Issue 1, 2012, Pages 117-121

  Benharroch, Daniel ^a   Osyntsov, Lidia ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Analogy; Cancer; Immunity; Infectious disease; Spread

Indexed keywords

ENDOSTATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CLINICAL FEATURE; GRANULOMA; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOSURVEILLANCE; INFECTION; LUNG CANCER; LYMPH FLOW; METASTASIS; NEOPLASM; NONHUMAN; OPPORTUNISTIC INFECTION; PSEUDOMONAS INFECTION; SCHISTOSOMIASIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 84881198522     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.3977     Document Type: Article

References (39)

1. Paterson R, Paterson E: Hodgkin's disease. Brit Med J; 1954;2: 1315-1318.
2. Petersdorf RG, Larson E: FUO revisited. Trans Am Clin Climatol Assoc; 1983, 94: 44-55.
3. Mims CA, Nash A, Stephen J. The spread of microbes through the body. Mims' pathogenesis of infectious diseases; 5th edi-tion. San Diego: Academic Press; 2001: 119-148.
4. Stricker TP, Kumar V. Neoplasia. In: Kumar V, et al, eds. Robbins and Cotran' Pathologic basis of disease; 8th edition. China: Saunders; 2010: 268-270; 286-295; 298-301; 316-320.
5. Mims CA, Nash A, Stephen J. The immune response to infection. Mims' pathogenesis of infectious diseases; 5th edition. San Diego: Academic Press; 2001:149-215.
6. Mims CA, Nash A, Stephen J. Attachment to and entry of microorganisms into the body. Mims' pathogenesis of infectious diseases; 5th edition. San Diego: Academic Press; 2001: 19-20; 25-30.
7. Stewardson AJ, Huttner B, Harbarth S. At least it won't hurt: the personal risk of antibiotic exposure. Curr Opin Pharmacol; 2011;11: 446-452.
8. Boccardo E, Lepique AP, Villa LL. The role of inflammation in HPV carcinogenesis. Carcinogenesis; 2010;31: 1905-1912.
9. Banys M, Gruber I, Krawczyk N, Becker S, Kurth L, Wallweiner D, Jakubowska J, Hoffman J, Rothmund R, Staebber A, Fehm T. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast. Breast Cancer Res Treat; 2011; [Epub ahead of print].
10. Petz JO, Stojandinovic A, Nissan A, Hohenberger W, Esquivel J. Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol; 2009;99: 9-15.
11. Mitchell RN. Hemodynamic disorders, thromboembolic disease, and shock. In: Kumar V, et al, eds. Robbins and Cotran's Pathologic basis of disease; 8th edition. China: Saunders; 2010:129-132; 319-320.
12. Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis; 2010;11: 142-151.
13. McAdam AJ, Sharpe AH. Infectious diseases. In: Kumar V, et al, eds. Robbins and Cotran's Pathologic basis of disease; 8th edition. China: Saunders; 2010: 346-347.
14. Drygiannakis I, Ernst PB, Lowe D, Glomski IJ. Immunological alterations mediated during host-microbial interactions. Immunol Res; 2011;50: 69-77.
15. Dubovsky JA, Villagra A, Powers JJ, Wang HW, Pinilla-Ibarz J, Sotomayor EM. Circumventing immune tolerance through epigenetic modification. Curr Pharm Des; 2010;16: 268-276.
16. Aptsiauri N, Cabrera T, Mendez R, Garcia-Lora A, Ruiz-Cabello F, Garrido F. Role of altered expression of HLA class I molecules in cancer progression. Adv Exp Med Biol; 2007;601: 123-131.
17. Boyton RJ, Altmann DM. Natural killer cells, killer Immunoglobulin-like receptors and human leukocyte antigen class I in disease. Clin Exp Immunol; 2007;149: 1-8.
18. Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrobial Chemother; 2011;66: 1431-1446.
19. Lin C-L, Kao J-H. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol; 2011;26(Suppl 1): 123-130.
20. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene; 2005;24: 6047-6057.
21. Longworth M, Laimins LA. Pathogenesis of human papilloma-viruses in differentiating epithelia. Microbiol Molec Biol Rev; 2004;68: 362-372.
22. Bodily J, Laimins LA. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol; 2011;19: 34-39.
23. Nguyen VTT, Law MG, Dore GJ. Hepatitis B-related hepato-cellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepatitis; 2009;16: 453-463.
24. McGivern DR, Lemon SM. Virus-specific mechanisms of carcinogenesis in hepatitis C virus-associated liver cancer. Oncogene; 2011;30: 1969-1983.
25. Saha A, Roberston ES. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res; 2011;17: 3056-3063.
26. Shao J-Y, Ernberg I, Biberfeld P, Heiden T, Zeng Y-X, Hu L-F. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leukocyte infiltration in nasopharyngeal carcinoma. Anticancer Res; 2004;24: 2309-2318.
27. Han van Krieken J. New developments in the pathology of malignant lymphoma. J Hematopathol; 2009;2: 50-61.
28. Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol; 2009;16: 236-246.
29. Zullo A, Hassan C, Andiani A, Cristofari F, De Francesco V, Ierardi E, Tomao S, Morini S, Vaira D. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma. Am J Gastroenterol; 2009;104: 1932-1937.
30. Bornshein J, Rokkas T, Selgrad M, Malfertheiner P. Helicobacter pylori and clinical aspects of gastric cancer. Helicobacter; 2009; 14 (Suppl 1): 41-45.
31. Colli C, Leinweber B, Mullegger R, Chott A, Kerl H, Cerroni I. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotype and molecular study of 106 cases. J Cutan Pathol; 2004;31: 232-240.
32. Takino H, Li C, Hu S, Kuo TT, Geissinger E, Muller-Hermelink HK, Kim B, Swerdlow SH, Inagaki H. Primary cutaneous marginal zone B-cell lymphoma: a molecular study of cases from Asia, Germany, and the United States. Modern Pathol; 2008;21: 1517-1528.
33. Ferreri AJM, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med; 2009;265: 421-438.
34. Stricker TP, Kumar V. Essential alterations for malignant transformation. In: Kumar V, et al, eds. Robbins and Cotran's Pathologic basis of disease; 8th edition. China: Saunders; 2010:278-279.
35. Robbins JR, Skrzypczynska KM, Zeldovich VP, Kapidzic M, Bakardjiev AI. Placental syncytiotrophoblast constitutes a major barrier to vertical transmission of Listeria monocytogenes. PLoS Pathog; 2010; 22: e1000732.
36. Altman JF, Lowe L, Redman B, Esper P, Schwartz JL, Johnson TM, Haefner HK. Placental metastasis of maternal melanoma. J Am Acad Dermatol; 2003;49: 1150-1154.
37. Folk JJ, Curioca J, Nosovitch JT Jr, Silverman RK. Poorly differentiated large cell adenocarcinoma of the lung metastatic to the placenta. J Rep Med; 2004;49: 395-397.
38. Shariati F, Perez-Arellaro JL, Carranza C, Lopez-Alban J, Vin-cente B, Arefi M, Muro A. Evaluation of the role of angiogenic factors in the pathogenesis of schistosomiasis. Exp Parasitol; 2011;128:44-49.
39. Martin C, Thevenot G, Danel S, Chapron J, Tazi A, Macey J, Dusser DJ, Fajac I, Burgel PR. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J; 2011;38: 939-946.